CN Patent

CN105939712A — 新方法

Assigned to Intra Cellular Therapies Inc · Expires 2016-09-14 · 10y expired

What this patent protects

本公开提供了特别取代的杂环稠合的γ‑咔啉化合物作为药物用于治疗精神病或精神分裂症残余症状的用途。本公开还提供了特别取代的杂环稠合的γ‑咔啉化合物的新的长效可注射制剂以及这类长效可注射制剂在治疗精神病或精神分裂症残余症状中的用途。

USPTO Abstract

本公开提供了特别取代的杂环稠合的γ‑咔啉化合物作为药物用于治疗精神病或精神分裂症残余症状的用途。本公开还提供了特别取代的杂环稠合的γ‑咔啉化合物的新的长效可注射制剂以及这类长效可注射制剂在治疗精神病或精神分裂症残余症状中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN105939712A
Jurisdiction
CN
Classification
—
Expires
2016-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Intra Cellular Therapies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.